Commercial Support

2022 webinars are provided free to AOFAS members and orthopaedic residents/fellows with funding from the Orthopaedic Foot & Ankle Foundation, supported by grants from:

Arthrex Inc. and Stryker.

AOFAS Mission Statement

The mission of the American Orthopaedic Foot & Ankle Society is to improve lives through exceptional orthopaedic foot and ankle care.

Target Audience

This course is designed for the experienced foot and ankle surgeon, the generalist orthopaedic surgeon interested in expanding their scope of practice into foot and ankle, post-residency fellows and residents who treat acute and chronic problems of the foot and ankle, and allied health professionals who work in foot and ankle care.

Description

This webinar offers the opportunity to learn from prestigious faculty with more than 100 collective years of experience managing the elite athlete with sport-related foot and ankle disorders. Faculty will share their insight on how to identify, communicate, and revise the complications and poor outcomes that may arise from surgical intervention in this unique patient population. Topics include revision considerations for Jones fractures, chronic ligament issues around the ankle, complications and revision options for navicular stress fractures, and poor outcomes of acute Achilles tendon repairs.

Course Objectives

At the conclusion of this webinar, you will be able to:

• Acknowledge the complications that can occur with surgical repair of sport-related foot and ankle disorders
• Understand the potential reasons for poor outcomes in various foot and ankle reconstruction in the athlete
• Appreciate the revision opportunities available for managing the complications associated with sport foot and ankle surgeries

Statement of Need

A need for this educational activity has been determined based on previous course/meeting evaluations, practice gap analysis, membership surveys, and the AOFAS educational curriculum. The content of this course was based on current issues and topics provided by AOFAS membership and leadership.

Program

The AOFAS attests that the person(s) responsible for the development of this educational activity did so independently and were not influenced by commercial supporters.

Accreditation

The American Orthopaedic Foot & Ankle Society (AOFAS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

Credit Designation Statement

The AOFAS designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Certificates

Participants are required to participate in the live program, answer the evaluation and claim CME at the end of the webinar.

Disclaimer

The material presented in this continuing medical education activity has been made available by the American Orthopaedic Foot & Ankle Society (AOFAS) for educational purposes only. This material is not intended to represent the only, nor necessarily the best, methods or procedures appropriate for the medical situation discussed, but rather is intended to present an approach, view, statement, or opinion of the authors or presenters, which may be helpful or of interest, to other practitioners.

Methods, techniques, and procedures demonstrated, and views and opinions expressed by speakers, presenters, and faculty are their own, and do not necessarily represent those of the AOFAS, nor does presentation on the program represent or constitute endorsement or promotion by the AOFAS. The AOFAS expressly disclaims any warranties or guarantees, expressed or implied, and shall not be liable for damages of any kind in connection with the material, methods, information, techniques, opinions, or procedures expressed, presented, or demonstrated.

A need for this educational activity has been determined based on previous course evaluations and the AOFAS educational curriculum. The content of this course was based on current issues and topics provided by AOFAS membership and leadership. For more information on the AOFAS CME mission, visit aofas.org/education.

AOFAS requires all instructors, planners, and other individuals in a position to control or influence the content of an educational activity to disclose all relevant financial relationships or affiliations during the past 12 months with any commercial interest (any entity producing, marketing, re-selling, or distributing healthcare goods and services consumed by, or used on patients). All identified conflicts of interest must be resolved and the education content vetted by AOFAS for fair balance, scientific objectivity, and appropriateness. AOFAS also requires faculty to disclose when off-label/unapproved uses of a product are discussed in a CME activity. AOFAS attests that the persons responsible for the development of this educational activity did so independently and were not influenced by commercial supporters. All financial disclosures will be provided to meeting attendees in the final program materials.

The material presented in this continuing medical education activity has been made available by the American Orthopaedic Foot & Ankle Society (AOFAS) for educational purposes only. This material is not intended to represent the only, nor necessarily the best, methods or procedures appropriate for the medical situation discussed, but rather is intended to present an approach, view, statement, or opinion of the authors or presenters, which may be helpful or of interest to other practitioners. Methods, techniques, and procedures demonstrated and views and opinions expressed by speakers, presenters, and faculty are their own, and do not necessarily represent those of AOFAS, nor does presentation on the program represent or constitute endorsement or promotion by AOFAS. AOFAS expressly disclaims any warranties or guarantees, expressed or implied, and shall not be liable for damages of any kind in connection with the material, methods, information, techniques, opinions, or procedures expressed, presented, or demonstrated.

FDA Statement
Some drugs or medical devices demonstrated at this meeting have not been cleared by the FDA or have been cleared by the FDA for specific purposes only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or medical devices he or she wishes to use in clinical practice. AOFAS policy provides that “off label” uses of a drug or medical device may be described in its CME activities so long as the “off label” use of the drug or medical device is also specifically disclosed (i.e., it must be disclosed that the FDA has not cleared the drug or device for the described purpose). Any drug or medical device is being used “off label” if the described use is not set forth on the products approval label.

Faculty/Planner Disclosure Declaration
As an Accreditation Council for Continuing Medical Education (ACCME) provider, AOFAS has the obligation to ensure the delivery of education that is balanced and free of commercial bias. To achieve this, it is the policy of the AOFAS that all CME-related board members, committee members (“planners”), faculty, and appropriate staff disclose in writing to the learners’ all financial relationships that you have had in the past 24 months with ineligible companies. An “ineligible company” are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

In addition to faculty members, commentators from the floor are charged with verbally disclosing any interests immediately prior to speaking. All disclosures are provided in this final program distributed at the meeting to all program participants.

In accordance with AOFAS policy:
Faculty participation in this educational activity will be predicated upon timely submission and review of AOFAS disclosure. An individual who refuses to disclose all financial relationships will be disqualified from being a planning committee member, a teacher, or an author of CME, and cannot have control of, or responsibility for, the development, management, presentation, or evaluation of the CME activity. Non-compliance will result in a faculty member being stricken from the program.

An indication of the participant’s disclosure appears after his or her name as well as the ineligible company that provided the support. AOFAS does not view the existence of these disclosed interests or commitments as necessarily implying bias or decreasing the value of the author’s participation in this activity. In addition to ensuring that presentations be free of bias, faculty members are required to ensure that all material presented and discussed will be based on best- available evidence.

Robert B. Anderson, MD The founding orthopaedic surgeon of the O.L. Miller Foot and Ankle Institute of OrthoCarolina in Charlotte, North Carolina, practicing there since 1989.  Joined the Titletown Sports Medicine and Orthopaedic Clinic in Green Bay in 2017.  Fellowship trained in foot and ankle disorders (Dr John Gould, Milwaukee WI ’88) with a large experience in sport related injuries.  Served as a team orthopaedist to the Carolina Panthers from 2000-2017 and since an associate team physician to the Green Bay Packers.  Has served as the chairman of the Foot and Ankle Subcommittee for the NFL since 2003 and the Chair of the NFL’s Musculoskeletal Committee since 2016, overseeing all orthopaedic injuries and research in professional football.  Is an active consultant to a number of NFL/NBA/NHL/MLB teams and colleges. 

Co-founder of the OrthoCarolina Foot and Ankle Fellowship program.  Chief of the Foot and Ankle Service at Carolinas Medical Center from 1989-2015.  Anderson is also a past-president of the American Orthopaedic Foot and Ankle Society.  Co-editor of the 9th edition of Mann’s: Surgery of the Foot and Ankle; former Editor-in-Chief of the journal, Techniques in Foot and Ankle Surgery; associate editor/reviewer for JBJS, JAAOS, FAI, AJSM and numerous other peer-review publications and author/editor of numerous chapters and manuscripts.

Born in Milwaukee, Wisconsin and attended the University of Mississippi where he was inducted into their Hall of Fame.

Dr. Coetzee earned his medical degree from the University of Pretoria School of Medicine in South Africa.  He completed his orthopedic residency at the University of Stellenbosch, South Africa, his trauma fellowship in Davos, Switzerland and a foot and ankle fellowship at the University of Washington and the Harborview Medical Center, in Seattle, WA, USA. Currently a  Foot and Ankle Orthopedic surgeon with Twin Cities Orthopedics in Minnesota. Official team Doctor for the Minnesota Vikings

Dr. Martin O'Malley is Associate Professor of Orthopaedic Surgery, Weil Cornell Hospital for PSecial Surgery.  He is team Physician for the Brooklyn Nets, USA Basketball, Iona College and Foot and Ankle Consultant to New York Giants

David Porter, MD, PhD received his PhD in Human Bioenergetics from Ball State Univ and his MD from Indiana University. Dr Porter has served as a partner and orthopedic Foot and Ankle specialist at Methodist Sports Medicine in Indianapolis for 23 years. Dr Porter was recognized in 2012 in the April 23rd edition of Street & Smith’s Sports Business Daily Journal as a leading specialist as it pertains to foot and ankle sports injuries and conditions. Dr Porter serves as the Foot and Ankle consultant to the Indianapolis Colts, Purdue University, Butler University and DePauw University. He is also a frequent consultant to teams in the NBA and NFL. He is co-author of Baxter’s: The Foot and Ankle in Sports (2nd and 3rd ed)

DISCLOSURE OF CONFLICT OF INTEREST

Disclosure Statement

AOFAS mandates all instructors, planners, and other individuals in a position to control or influence the content of an educational activity to disclose all financial relationships that you have had in the past 24 months with ineligible companies. An “ineligible company” are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

All identified conflicts must be mitigated, and the education content vetted by the AOFAS for fair balance, scientific objectivity, and appropriateness. All disclosures will be provided in this final program distributed at the meeting to all program participants.

FDA Statement

Some drugs or medical devices demonstrated at this meeting have not been cleared by the FDA or have been cleared by the FDA for specific purposes only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or medical devices he or she wishes to use in clinical practice. AOFAS policy provides that “off label” uses of a drug or medical device may be described in its CME activities so long as the “off label” use of the drug or medical device is also specifically disclosed (i.e., it must be disclosed that the FDA has not cleared the drug or device for the described purpose). Any drug or medical device is being used “off label” if the described use is not set forth on the products approval label.

Faculty/Planner Disclosure Declaration

As an Accreditation Council for Continuing Medical Education (ACCME) provider, AOFAS has the obligation to ensure the delivery of education that is balanced and free of commercial bias. To achieve this, it is the policy of the AOFAS that all CME-related Board, committee members (“planners”), faculty, and appropriate staff disclose in writing to the learners’ all financial relationships that you have had in the past 24 months with ineligible companies. An “ineligible company” are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

In addition to faculty members, commentators from the floor are charged with verbally disclosing any interests immediately prior to speaking. All disclosures are provided in this final program distributed at the meeting to all program participants.

In accordance with AOFAS policy:

Faculty participation in this educational activity will be predicated upon timely submission and review of AOFAS disclosure. An individual who refuses to disclose all financial relationships will be disqualified from being a planning committee member, a teacher, or an author of CME, and cannot have control of, or responsibility for, the development, management, presentation, or evaluation of the CME activity. Non-compliance will result in a faculty member being stricken from the program.

An indication of the participant’s disclosure appears after his or her name as well as the ineligible company that provided the support. AOFAS does not view the existence of these disclosed interests or commitments as necessarily implying bias or decreasing the value of the author’s participation in this activity. In addition to ensuring that presentations be free of bias, faculty

members are required to ensure that all material presented and discussed will be based on best- available evidence.

Webinar Faculty Disclosures

Robert Anderson, MD

Zimmer: Royalties, Paid Consultant

Arthrex Inc: Paid Consultant

Nuvasive: Paid Consultant

Artelon: Paid Consultant

Saunders/Mosby-Elsevier: Royalties, Financial or Material Support from Publishers

Amniox: Paid Consultant

Bioventus: Paid Consultant

J. Chris Coetzee, MD

Smith & Nephew: Paid Consultant; Royalties; Speaker's Bureau/Presenter

Elsevier: Royalties, Financial or Material Support from Publishers

Biomet: Royalties

Bio2 Technologies: Stock or Stock Options

CrossRoads Extremity Systems: Stock or Stock Options

Responsive Arthroscopy: Stock or Stock Options

Johnson & Johnson: Royalties

Arthrex Inc: Royalties

Medtronic: Paid Consultant

Responsive Arthroscopy: Stock or Stock Options

Martin O’Malley, MD

Curvebeam: Stock or Stock Options; Royalties

Nextremity Medical: Royalties

David Porter, MD

Physician Rehab Solutions: Paid Consultant

ROMtech: Stock or Stock Options

Elsevier: Royalties, Financial or Material Support from Publishers

American Orthopaedic Foot and Ankle Society: Board member/committee appointments for a society

Tayco Brace: Stock or Stock Options

AOFAS Research Grant: Research Support

EDUCATION COMMITTEE DISCLOSURES (Planners)

Mohamed Abd-Ella, MD

   This individual reported nothing to disclose

Jonathon D. Backus, MD

American Orthopaedic Foot and Ankle Society: Board or committee member

Arthrex Inc: Speaker’s Bureau/Presenter

Medline UNITE: Paid Consultant

Marrow Access Technologies: Stock or Stock Options

Callum Clark, MD

This individual reported nothing to disclose

M. Truitt Cooper, MD

This individual reported nothing to disclose

Daniel C Farber, MD

This individual reported nothing to disclose

Alena Frey

Staff

This individual reported nothing to disclose

Lauren Elizabeth Geaney, MD

American Orthopaedic Foot and Ankle Society: Board or committee member

Arthrex, Inc: Research support

Connecticut Orthopaedic Society: Board or committee member Paragon 28: Paid consultant

Smith & Nephew: Paid consultant

Vilex: Paid consultant

Techniques in Orthopaedics: Editorial or governing board

Techniques in Foot and Ankle Surgery: Editorial or governing board

Foot and Ankle International: Editorial or governing board

Julie Glosson

Staff

This individual reported nothing to disclose

Daniel Guss, MD

American Orthopaedic Foot and Ankle Society: Board or committee member

Arthrex Inc: Research Support

Butterfly, Inc: Research Support

Ossio: Paid Consultant, Stock or Stock options

DJO/AOFAS Traveling Fellowship: Other Financial or Material Support

AOFAS Traveling Fellowship 2019: Other Financial or Material Support

Tracy Harig, MD

This individual reported nothing to disclose

Thomas M Hearty, MD

American Orthopaedic Foot and Ankle Society: Board or committee member

Orthobullets: Editorial or governing board

Casey Humbyrd, MD

American Orthopaedic Foot and Ankle Society: Board or committee member

AAOS: Board or committee member

Oxford University Press: Royalties, Financial or Material Support from Publishers

Kelly K. Hynes, MD

  Acumed LLC: Speaker’s Bureau/Presenter, Paid Consultant

  BoneSupport: Speaker’s Bureau/Presenter

James Robert Lachman, MD

American Orthopaedic Foot and Ankle Society: Board or committee member

Arthrex Inc: Speaker’s Bureau/Presenter

FlowFX: Unpaid Consultant

Foot and Ankle International: Editorial or governing board

Oxford University Press: Royalties, Financial or Material Support from Publishers

Elizabeth Martin, MD

American Orthopaedic Foot and Ankle Society: Board or committee member

James Meeker, MD

American Orthopaedic Foot and Ankle Society: Board or committee member

Jennifer Moore

Staff

This individual reported nothing to disclose

Irvin Oh, MD

Innomed: IP royalties

Christian A. Ortiz, MD

Synthes, Gmreis: Speaker’s Bureau/Presenter, Paid Consultant

STEPS2walk: Editorial or governing board

IFFAS: Board or committee member

Charles Saltzman, MD

Zimmer: Royalites

Smith & Nephew: Paid Consultant

Lima: Unpaid Consultant

Crossroads Extremities: Stock or Stock Options

Bio2: Stock or Stock Options

Elsevier: Royalties, Financial or Material Support from Publishers

João Filipe Vide, MD

American Orthopaedic Foot and Ankle Society: Board or committee member

European Federation of National Associations of Orthopedics and Traumatology: Board or committee member

Federation of Orthopaedic Trainees in Europe: Board or committee member

Arthrex Inc: Paid Consultant, Speaker’s Bureau/Presenter

Knee Surgery, Sports traumatology, Arthroscopy: Editorial or governing board

Brian M Weatherford, MD

BESPA Global: Paid consultant

Orthobullets: Paid consultant

Synthes: Paid presenter or speaker

Richard Zell, MD

   American Orthopaedic Foot and Ankle Society: Board or committee member

   This individual reported nothing to disclose

Jacob Rothschild Zide, MD

American Orthopaedic Foot and Ankle Society: Board or committee member

Orthofix: Paid consultant

All of the relevant financial relationships listed for these individuals have been mitigated.